 NEW YORK, Feb. 10, 2022 GLOBE NEWSWIRE -- Intra-Cellular Therapies, Inc. Nasdaq: ITCI, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system CNS disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 8:40 am ET. 